Alkermes (ALKS) Earnings Date & Reports

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALKS is expected to report earnings to rise 199.00% to 38 cents per share on July 23

Q2'25

Est.

$0.39

Q1'25

Missed

by $0.18

Q4'24

Beat

by $0.30

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.04

The last earnings report on May 01 showed earnings per share of 12 cents, missing the estimate of 31 cents. With 725.91K shares outstanding, the current market capitalization sits at 4.55B.

View a ticker or compare two or three

Compare

ALKS